| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |